gliptin and glp-1 Schematic presentation of glucagon-like peptide-1 (GLP-1)-dependent sitagliptin [TUSOM | Pharmwiki]

Preclinical studies have already demonstrated the beneficial effects of GLP-1 on myocardium and vascular endothelium, and many clinical studies evaluating changes in surrogate markers of CVD have suggested potential benefits from the use of GLP-1 RAs

Moreover, participants reported improvements in several obesity-related health markers, such as waist circumference, blood pressure, and quality of life measures

Heres What You Need to Do If youre currently taking a GLP-1 or considering it, its not all doom and gloom

Peptides are short chains of amino acids bound together by peptide bonds

Conclusion A better understanding of the pathophysiology of these hormones is of a great interest in order to clarify their burden in emerging diseases (such as obesity) not only for their treatment, but also in order to prevent their appearance and progression

The best action is to consult with a provider through Klinic's online visit